The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...
The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...
A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans at risk for ...
The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...
A popular diabetes drug just got a major new approval—and it could be a game-changer for millions of Americans at risk for ...